SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-09-029190
Filing Date
2009-02-13
Accepted
2009-02-13 15:49:17
Documents
1
Group Members
ABINGWORTH LLP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 3 dsc13ga.htm SC 13G/A 67401
  Complete submission text file 0001193125-09-029190.txt   69369
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Subject) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-40119 | Film No.: 09603128
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 20 7534 1508
Abingworth Management LTD (Filed by) CIK: 0001291892 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A